Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Primary Forms 1.4.3 Secondary Forms 1.5 Market by Application 1.5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Ambulatory Surgical Centers 1.5.5 Research Institutes 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Perspective (2015-2026) 2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Growth Trends by Regions 2.2.1 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Market Size 3.1.1 Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Revenue (2015-2020) 3.1.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio 3.2.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2019 3.3 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players Head office and Area Served 3.4 Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service 3.5 Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Historic Market Size by Type (2015-2020) 4.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Type (2021-2026) 5 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Breakdown Data by Application (2015-2026) 5.1 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 5.2 Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020) 6.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in North America (2019-2020) 6.3 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 6.4 North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020) 7.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Europe (2019-2020) 7.3 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 7.4 Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 8 China 8.1 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020) 8.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in China (2019-2020) 8.3 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 8.4 China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020) 9.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Japan (2019-2020) 9.3 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 9.4 Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020) 10.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 11 India 11.1 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020) 11.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in India (2019-2020) 11.3 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 11.4 India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size (2015-2020) 12.2 Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) 12.4 Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 13.1.4 Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Novartis 13.2.1 Novartis Company Details 13.2.2 Novartis Business Overview and Its Total Revenue 13.2.3 Novartis Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 13.2.4 Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 13.2.5 Novartis Recent Development 13.3 AstraZeneca 13.3.1 AstraZeneca Company Details 13.3.2 AstraZeneca Business Overview and Its Total Revenue 13.3.3 AstraZeneca Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 13.3.4 AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 13.3.5 AstraZeneca Recent Development 13.4 Merck 13.4.1 Merck Company Details 13.4.2 Merck Business Overview and Its Total Revenue 13.4.3 Merck Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 13.4.4 Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 13.4.5 Merck Recent Development 13.5 Sanofi 13.5.1 Sanofi Company Details 13.5.2 Sanofi Business Overview and Its Total Revenue 13.5.3 Sanofi Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 13.5.4 Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 13.5.5 Sanofi Recent Development 13.6 Daiichi Sankyo 13.6.1 Daiichi Sankyo Company Details 13.6.2 Daiichi Sankyo Business Overview and Its Total Revenue 13.6.3 Daiichi Sankyo Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 13.6.4 Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 13.6.5 Daiichi Sankyo Recent Development 13.7 Bayer 13.7.1 Bayer Company Details 13.7.2 Bayer Business Overview and Its Total Revenue 13.7.3 Bayer Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Introduction 13.7.4 Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) 13.7.5 Bayer Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Table 3. Ranking of Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Primary Forms Table 6. Key Players of Secondary Forms Table 7. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2015-2020) Table 11. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Growth Strategy Table 17. Main Points Interviewed from Key Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players Table 18. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue by Players (2015-2020) (Million US$) Table 19. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players (2015-2020) Table 20. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2019) Table 21. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Product Solution and Service Table 24. Date of Enter into Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 27. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Type (2015-2020) Table 28. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2015-2020) Table 30. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 31. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size Share by Application (2021-2026) Table 32. North America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$) Table 33. North America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020) Table 34. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 35. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 36. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 37. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 38. Europe Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020) Table 40. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 41. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 42. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 43. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 44. China Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$) Table 45. China Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020) Table 46. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 47. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 48. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 49. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 50. Japan Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020) Table 52. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 53. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 54. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 55. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020) Table 58. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 60. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 62. India Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$) Table 63. India Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020) Table 64. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 65. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 66. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 67. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 68. Central & South America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share (2019-2020) Table 70. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type (2015-2020) Table 72. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application (2015-2020) Table 74. Pfizer Company Details Table 75. Pfizer Business Overview Table 76. Pfizer Product Table 77. Pfizer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$) Table 78. Pfizer Recent Development Table 79. Novartis Company Details Table 80. Novartis Business Overview Table 81. Novartis Product Table 82. Novartis Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$) Table 83. Novartis Recent Development Table 84. AstraZeneca Company Details Table 85. AstraZeneca Business Overview Table 86. AstraZeneca Product Table 87. AstraZeneca Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$) Table 88. AstraZeneca Recent Development Table 89. Merck Company Details Table 90. Merck Business Overview Table 91. Merck Product Table 92. Merck Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$) Table 93. Merck Recent Development Table 94. Sanofi Company Details Table 95. Sanofi Business Overview Table 96. Sanofi Product Table 97. Sanofi Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$) Table 98. Sanofi Recent Development Table 99. Daiichi Sankyo Company Details Table 100. Daiichi Sankyo Business Overview Table 101. Daiichi Sankyo Product Table 102. Daiichi Sankyo Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$) Table 103. Daiichi Sankyo Recent Development Table 104. Bayer Company Details Table 105. Bayer Business Overview Table 106. Bayer Product Table 107. Bayer Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) (Million US$) Table 108. Bayer Recent Development Table 109. Research Programs/Design for This Report Table 110. Key Data Information from Secondary Sources Table 111. Key Data Information from Primary Sources List of Figures Figure 1. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Type: 2020 VS 2026 Figure 2. Primary Forms Features Figure 3. Secondary Forms Features Figure 4. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Clinics Case Studies Figure 7. Ambulatory Surgical Centers Case Studies Figure 8. Research Institutes Case Studies Figure 9. Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Report Years Considered Figure 10. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Share by Players in 2019 Figure 15. Global Top Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Revenue in 2019 Figure 17. North America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Pfizer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Novartis Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 28. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. AstraZeneca Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Merck Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 32. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Sanofi Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 34. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Daiichi Sankyo Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 36. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Bayer Revenue Growth Rate in Postural Orthostatic Tachycardia Syndrome (POTS) Treatment Business (2015-2020) Figure 38. Bottom-up and Top-down Approaches for This Report Figure 39. Data Triangulation Figure 40. Key Executives Interviewed

Pfizer Novartis AstraZeneca Merck Sanofi Daiichi Sankyo Bayer